CyberHeart Raises $9 Million

CyberHeart Inc., a Menlo Park, Calif.-based developer of a non-invasive system to treat cardiac arrhythmias, has raised $9 million in Series A funding. Emergent Medical Ventures and United Investments (Taiwan) co-led the round, and were joined by Venture Select GmbH and Mitsubishi Corporation.



CyberHeart Incorporated, a Menlo Park, Calif-based medical device company developing the first totally non-invasive system to treat cardiac arrhythmias, today announced the close of a $9 million Series A financing. The investment was co-led by Emergent Medical Ventures, LLP (Portola Valley, Calif.) and United Investments (Taipei, Taiwan). Also participating in the round were Venture Select GmbH (Munich, Germany) and Mitsubishi Corporation (New York, NY).

“We are pleased to have secured such knowledgeable and high caliber investors in this critical initial funding,” said Patrick Maguire, M.D., Ph.D., president and CEO of CyberHeart Incorporated.

CyberHeart plans to use the financing to fund the development of proprietary non-invasive technology for cardiac applications using the CyberKnife(